Gene Symbol | Gene ID | Gene Info |
---|---|---|
Scrt1
|
ENSMUSG00000048385.8 | scratch family zinc finger 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_76522469_76523177 | Scrt1 | 324 | 0.717878 | -0.89 | 6.8e-20 | Click! |
chr15_76523197_76523402 | Scrt1 | 800 | 0.352060 | -0.88 | 5.5e-19 | Click! |
chr15_76517232_76517738 | Scrt1 | 4417 | 0.080616 | -0.87 | 6.1e-18 | Click! |
chr15_76520651_76521002 | Scrt1 | 1076 | 0.254864 | -0.84 | 1.0e-15 | Click! |
chr15_76522202_76522451 | Scrt1 | 173 | 0.859421 | -0.82 | 2.3e-14 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_82225804_82226178 | 20.12 |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
30594 |
0.19 |
chr7_127091121_127091448 | 17.11 |
AI467606 |
expressed sequence AI467606 |
75 |
0.92 |
chr11_32284592_32284892 | 16.45 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
931 |
0.37 |
chr12_103956494_103956864 | 16.12 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
219 |
0.88 |
chr12_103737920_103738559 | 16.07 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr15_83474131_83474367 | 13.77 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
9643 |
0.14 |
chr13_98890078_98890869 | 13.47 |
Tnpo1 |
transportin 1 |
525 |
0.72 |
chr9_113969020_113969322 | 13.46 |
Ubp1 |
upstream binding protein 1 |
54 |
0.97 |
chr2_158145791_158146607 | 13.32 |
Tgm2 |
transglutaminase 2, C polypeptide |
167 |
0.94 |
chr10_87546947_87547105 | 13.22 |
Pah |
phenylalanine hydroxylase |
353 |
0.9 |
chr15_83425276_83425627 | 13.16 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
1661 |
0.32 |
chr7_100466963_100467472 | 13.00 |
Gm10603 |
predicted gene 10603 |
27 |
0.95 |
chr9_110668886_110669048 | 12.79 |
Ccdc12 |
coiled-coil domain containing 12 |
2042 |
0.19 |
chr2_84842012_84842290 | 12.67 |
Slc43a1 |
solute carrier family 43, member 1 |
1526 |
0.26 |
chr2_32128379_32128667 | 12.11 |
Prrc2b |
proline-rich coiled-coil 2B |
22559 |
0.1 |
chr1_134741550_134741897 | 11.86 |
Syt2 |
synaptotagmin II |
6854 |
0.17 |
chr12_25092319_25093283 | 11.77 |
Id2 |
inhibitor of DNA binding 2 |
3286 |
0.21 |
chr10_115263315_115263511 | 11.69 |
Gm8942 |
predicted gene 8942 |
6565 |
0.17 |
chr10_77130088_77130939 | 11.06 |
Gm7775 |
predicted gene 7775 |
6587 |
0.19 |
chr12_84203574_84203922 | 10.99 |
Gm31513 |
predicted gene, 31513 |
7779 |
0.11 |
chr7_143986580_143986731 | 10.98 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
15273 |
0.17 |
chr2_21234723_21234882 | 10.92 |
Gm13378 |
predicted gene 13378 |
9303 |
0.18 |
chr7_96959235_96959424 | 10.85 |
C230038L03Rik |
RIKEN cDNA C230038L03 gene |
7443 |
0.19 |
chr3_106494529_106494709 | 10.81 |
Dennd2d |
DENN/MADD domain containing 2D |
1444 |
0.31 |
chr14_69536637_69537045 | 10.47 |
Gm27174 |
predicted gene 27174 |
18491 |
0.09 |
chr14_121368328_121368483 | 10.35 |
Stk24 |
serine/threonine kinase 24 |
8537 |
0.21 |
chr2_151038017_151038184 | 10.25 |
Nanp |
N-acetylneuraminic acid phosphatase |
1262 |
0.26 |
chr6_116286832_116287192 | 10.20 |
Zfand4 |
zinc finger, AN1-type domain 4 |
459 |
0.75 |
chrX_101428817_101430172 | 10.11 |
Nono |
non-POU-domain-containing, octamer binding protein |
61 |
0.96 |
chr15_25663141_25663443 | 9.72 |
Myo10 |
myosin X |
11218 |
0.18 |
chr16_36893419_36893598 | 9.52 |
Gm49600 |
predicted gene, 49600 |
886 |
0.4 |
chr9_114554657_114554997 | 9.47 |
Trim71 |
tripartite motif-containing 71 |
9542 |
0.17 |
chr2_104078841_104079036 | 9.28 |
Cd59b |
CD59b antigen |
7872 |
0.11 |
chr1_77298959_77299132 | 9.26 |
Epha4 |
Eph receptor A4 |
78562 |
0.11 |
chr5_110797730_110798044 | 9.15 |
Ulk1 |
unc-51 like kinase 1 |
2053 |
0.19 |
chr17_83973556_83973707 | 9.10 |
Gm41638 |
predicted gene, 41638 |
12701 |
0.11 |
chr15_99651541_99652191 | 9.08 |
Racgap1 |
Rac GTPase-activating protein 1 |
210 |
0.88 |
chr10_108408546_108408758 | 9.06 |
Gm36283 |
predicted gene, 36283 |
8599 |
0.19 |
chr13_37666246_37666836 | 9.03 |
AI463229 |
expressed sequence AI463229 |
1 |
0.96 |
chr18_68230237_68230503 | 9.00 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
2303 |
0.29 |
chr16_97953407_97953575 | 8.86 |
Zbtb21 |
zinc finger and BTB domain containing 21 |
393 |
0.84 |
chr11_107397698_107397986 | 8.78 |
Gm11712 |
predicted gene 11712 |
10859 |
0.13 |
chr5_137569704_137569886 | 8.76 |
Tfr2 |
transferrin receptor 2 |
45 |
0.93 |
chr17_33920147_33920573 | 8.76 |
Gm19412 |
predicted gene, 19412 |
71 |
0.59 |
chr6_90710016_90710235 | 8.76 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
6404 |
0.17 |
chr17_71093701_71093944 | 8.66 |
Myom1 |
myomesin 1 |
7426 |
0.17 |
chr9_107369362_107369529 | 8.65 |
4930429P21Rik |
RIKEN cDNA 4930429P21 gene |
15459 |
0.1 |
chr18_62166142_62166444 | 8.54 |
Adrb2 |
adrenergic receptor, beta 2 |
13666 |
0.18 |
chr5_118488782_118489619 | 8.49 |
Gm15754 |
predicted gene 15754 |
2233 |
0.32 |
chr9_50924434_50924623 | 8.45 |
Gm25558 |
predicted gene, 25558 |
36578 |
0.13 |
chr2_152406114_152406779 | 8.42 |
Sox12 |
SRY (sex determining region Y)-box 12 |
8383 |
0.08 |
chr10_80075046_80075222 | 8.41 |
Sbno2 |
strawberry notch 2 |
266 |
0.82 |
chrX_150547265_150547522 | 8.38 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
18 |
0.52 |
chr10_94020675_94020940 | 8.34 |
Vezt |
vezatin, adherens junctions transmembrane protein |
84 |
0.95 |
chr11_84867737_84867937 | 8.34 |
Ggnbp2 |
gametogenetin binding protein 2 |
2365 |
0.18 |
chr2_84682920_84683088 | 8.20 |
Med19 |
mediator complex subunit 19 |
2629 |
0.11 |
chr15_83169975_83170350 | 8.20 |
Cyb5r3 |
cytochrome b5 reductase 3 |
15 |
0.95 |
chr19_32476810_32477003 | 8.20 |
Minpp1 |
multiple inositol polyphosphate histidine phosphatase 1 |
8863 |
0.14 |
chr4_141751480_141751732 | 8.19 |
Agmat |
agmatine ureohydrolase (agmatinase) |
4934 |
0.14 |
chr9_110653586_110654769 | 8.18 |
Nbeal2 |
neurobeachin-like 2 |
16 |
0.94 |
chr10_58393506_58393821 | 8.17 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
710 |
0.69 |
chr1_136007953_136008157 | 8.10 |
Tmem9 |
transmembrane protein 9 |
95 |
0.95 |
chr10_54073616_54073789 | 7.99 |
Man1a |
mannosidase 1, alpha |
2007 |
0.28 |
chr18_64485762_64485936 | 7.99 |
Fech |
ferrochelatase |
3092 |
0.21 |
chr17_23684213_23684592 | 7.99 |
Cldn9 |
claudin 9 |
376 |
0.62 |
chr11_109554522_109554844 | 7.92 |
Arsg |
arylsulfatase G |
10929 |
0.16 |
chr6_127356580_127356780 | 7.90 |
Gm43631 |
predicted gene 43631 |
11799 |
0.14 |
chr4_43605427_43605591 | 7.88 |
Gm12472 |
predicted gene 12472 |
17437 |
0.06 |
chr11_49249936_49250117 | 7.87 |
Mgat1 |
mannoside acetylglucosaminyltransferase 1 |
486 |
0.7 |
chr1_165765728_165766269 | 7.87 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
2252 |
0.15 |
chr15_73212141_73212465 | 7.84 |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
2812 |
0.25 |
chr2_91256510_91257912 | 7.83 |
Pacsin3 |
protein kinase C and casein kinase substrate in neurons 3 |
118 |
0.94 |
chr3_131283448_131283608 | 7.78 |
Gm18492 |
predicted gene, 18492 |
1616 |
0.31 |
chr5_143547515_143547679 | 7.77 |
Fam220a |
family with sequence similarity 220, member A |
1109 |
0.41 |
chr19_42118241_42118392 | 7.76 |
Pi4k2a |
phosphatidylinositol 4-kinase type 2 alpha |
3638 |
0.14 |
chr3_94926682_94926833 | 7.74 |
Selenbp1 |
selenium binding protein 1 |
6299 |
0.1 |
chr6_125572722_125573175 | 7.71 |
Vwf |
Von Willebrand factor |
6697 |
0.22 |
chr6_4484046_4484465 | 7.66 |
Gm37883 |
predicted gene, 37883 |
57 |
0.97 |
chr7_142393276_142393477 | 7.65 |
Ctsd |
cathepsin D |
5338 |
0.11 |
chr19_47430280_47430461 | 7.63 |
Sh3pxd2a |
SH3 and PX domains 2A |
20011 |
0.19 |
chr15_9472966_9473152 | 7.59 |
Gm50456 |
predicted gene, 50456 |
2443 |
0.31 |
chr1_75179330_75179529 | 7.57 |
Abcb6 |
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
480 |
0.55 |
chr7_108797627_108797969 | 7.56 |
Gm45232 |
predicted gene 45232 |
2795 |
0.17 |
chr2_127548794_127548954 | 7.56 |
Prom2 |
prominin 2 |
7407 |
0.13 |
chr1_132360200_132360992 | 7.56 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
4352 |
0.14 |
chr16_49800522_49800679 | 7.52 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
67 |
0.97 |
chr8_126615474_126615664 | 7.49 |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
21583 |
0.21 |
chr19_24999677_24999851 | 7.49 |
Dock8 |
dedicator of cytokinesis 8 |
220 |
0.94 |
chr14_101846706_101846861 | 7.47 |
Lmo7 |
LIM domain only 7 |
5964 |
0.29 |
chr18_24101383_24101635 | 7.46 |
Ino80c |
INO80 complex subunit C |
13404 |
0.18 |
chr7_110221164_110221323 | 7.46 |
Swap70 |
SWA-70 protein |
468 |
0.81 |
chr5_97007576_97007868 | 7.45 |
Bmp2k |
BMP2 inducible kinase |
10033 |
0.14 |
chr2_146577252_146577409 | 7.42 |
4933406D12Rik |
RIKEN cDNA 4933406D12 gene |
34399 |
0.2 |
chr1_195092219_195092480 | 7.39 |
Cd46 |
CD46 antigen, complement regulatory protein |
100 |
0.95 |
chr14_7952438_7953164 | 7.38 |
Gm45521 |
predicted gene 45521 |
4487 |
0.21 |
chr11_107337371_107337788 | 7.34 |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
53 |
0.88 |
chr16_8811325_8811490 | 7.33 |
1810013L24Rik |
RIKEN cDNA 1810013L24 gene |
18693 |
0.15 |
chr17_79364838_79365021 | 7.33 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
9838 |
0.22 |
chr6_55324727_55325118 | 7.32 |
Aqp1 |
aquaporin 1 |
11510 |
0.14 |
chr15_44457390_44457901 | 7.32 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
92 |
0.97 |
chr12_99435607_99435758 | 7.30 |
Foxn3 |
forkhead box N3 |
14392 |
0.18 |
chr7_120129056_120129210 | 7.28 |
Zp2 |
zona pellucida glycoprotein 2 |
13804 |
0.12 |
chr7_143004700_143005061 | 7.28 |
Tspan32 |
tetraspanin 32 |
166 |
0.92 |
chr16_30045625_30045837 | 7.24 |
9030404E10Rik |
RIKEN cDNA 9030404E10 gene |
6252 |
0.16 |
chr11_84823027_84823209 | 7.23 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
3603 |
0.14 |
chr13_44733414_44734122 | 7.22 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
272 |
0.94 |
chr14_69318389_69318982 | 7.20 |
Gm16677 |
predicted gene, 16677 |
18397 |
0.08 |
chr9_67593595_67593746 | 7.18 |
Tln2 |
talin 2 |
33967 |
0.19 |
chr11_97427734_97428829 | 7.17 |
Arhgap23 |
Rho GTPase activating protein 23 |
8004 |
0.16 |
chr19_57521914_57522065 | 7.16 |
Gm32932 |
predicted gene, 32932 |
268 |
0.88 |
chr11_77372346_77372497 | 7.16 |
Ssh2 |
slingshot protein phosphatase 2 |
19016 |
0.17 |
chr12_110975514_110975665 | 7.13 |
Ankrd9 |
ankyrin repeat domain 9 |
2666 |
0.17 |
chr2_32464470_32464843 | 7.13 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
13211 |
0.1 |
chr1_185454557_185455710 | 7.12 |
Slc30a10 |
solute carrier family 30, member 10 |
95 |
0.83 |
chr15_80645463_80645691 | 7.11 |
Mir6957 |
microRNA 6957 |
496 |
0.72 |
chr13_75734196_75734501 | 7.10 |
Gm48302 |
predicted gene, 48302 |
7069 |
0.14 |
chr12_83473991_83474302 | 7.07 |
Dpf3 |
D4, zinc and double PHD fingers, family 3 |
13562 |
0.18 |
chr10_41205578_41205924 | 7.04 |
Gm25526 |
predicted gene, 25526 |
10294 |
0.2 |
chr5_64566775_64566964 | 7.02 |
Gm42566 |
predicted gene 42566 |
2050 |
0.21 |
chr9_32607649_32607944 | 7.01 |
Gm47680 |
predicted gene, 47680 |
5656 |
0.16 |
chr10_42260931_42261096 | 7.00 |
Foxo3 |
forkhead box O3 |
2647 |
0.36 |
chr6_31658824_31659102 | 7.00 |
Gm43154 |
predicted gene 43154 |
4929 |
0.2 |
chr11_106046550_106046858 | 6.99 |
Gm11646 |
predicted gene 11646 |
5148 |
0.11 |
chr2_155606458_155606631 | 6.97 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
4668 |
0.09 |
chr1_74961721_74962010 | 6.95 |
Gm37744 |
predicted gene, 37744 |
7613 |
0.12 |
chr3_27270180_27270471 | 6.94 |
Gm37191 |
predicted gene, 37191 |
7735 |
0.2 |
chr1_132026947_132027256 | 6.93 |
Mfsd4a |
major facilitator superfamily domain containing 4A |
1932 |
0.25 |
chr8_110928646_110928831 | 6.92 |
St3gal2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
3183 |
0.14 |
chr4_156059376_156059580 | 6.90 |
Ttll10 |
tubulin tyrosine ligase-like family, member 10 |
64 |
0.77 |
chr14_120271491_120271680 | 6.88 |
Mbnl2 |
muscleblind like splicing factor 2 |
4084 |
0.31 |
chr18_78123750_78123915 | 6.86 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
406 |
0.88 |
chr16_90988459_90988610 | 6.85 |
Gm15965 |
predicted gene 15965 |
4627 |
0.12 |
chr11_94290511_94290668 | 6.85 |
Luc7l3 |
LUC7-like 3 (S. cerevisiae) |
2634 |
0.21 |
chr7_25249061_25250506 | 6.85 |
Erf |
Ets2 repressor factor |
947 |
0.33 |
chr15_96834486_96834759 | 6.82 |
Gm8888 |
predicted gene 8888 |
67544 |
0.11 |
chr1_129956505_129956749 | 6.81 |
Gm37278 |
predicted gene, 37278 |
13465 |
0.22 |
chr4_120666293_120666935 | 6.80 |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
42 |
0.97 |
chr11_54804054_54804205 | 6.79 |
Lyrm7os |
LYR motif containing 7, opposite strand |
15790 |
0.12 |
chr8_61908569_61908914 | 6.78 |
4930512H18Rik |
RIKEN cDNA 4930512H18 gene |
4319 |
0.19 |
chr1_165193825_165195060 | 6.78 |
Sft2d2 |
SFT2 domain containing 2 |
4 |
0.97 |
chr16_95855291_95855553 | 6.76 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
9652 |
0.19 |
chr4_88032518_88033581 | 6.76 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
232 |
0.71 |
chr1_120258655_120258865 | 6.75 |
Steap3 |
STEAP family member 3 |
6495 |
0.26 |
chr12_76558245_76558525 | 6.73 |
Plekhg3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
3853 |
0.17 |
chr17_86503336_86503487 | 6.73 |
Gm10309 |
predicted gene 10309 |
1821 |
0.4 |
chr3_116695078_116695237 | 6.73 |
Gm43191 |
predicted gene 43191 |
13897 |
0.11 |
chr1_82239944_82240095 | 6.71 |
Gm9747 |
predicted gene 9747 |
6907 |
0.23 |
chr4_145219707_145219907 | 6.67 |
Vps13d |
vacuolar protein sorting 13D |
24802 |
0.17 |
chrX_71526037_71526198 | 6.67 |
Gm23945 |
predicted gene, 23945 |
5259 |
0.19 |
chr17_5941337_5942051 | 6.67 |
Synj2 |
synaptojanin 2 |
291 |
0.89 |
chr18_20939157_20939308 | 6.66 |
Rnf125 |
ring finger protein 125 |
5393 |
0.23 |
chr4_135494313_135495270 | 6.65 |
Stpg1 |
sperm tail PG rich repeat containing 1 |
1 |
0.68 |
chr4_59717558_59717753 | 6.63 |
E130308A19Rik |
RIKEN cDNA E130308A19 gene |
15603 |
0.2 |
chr5_108483140_108483295 | 6.62 |
Pcgf3 |
polycomb group ring finger 3 |
3003 |
0.16 |
chr2_121442116_121442476 | 6.61 |
Ell3 |
elongation factor RNA polymerase II-like 3 |
305 |
0.74 |
chr5_35162229_35162407 | 6.61 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
56552 |
0.11 |
chr2_167833383_167834006 | 6.61 |
1200007C13Rik |
RIKEN cDNA 1200007C13 gene |
48 |
0.97 |
chr14_27296899_27297050 | 6.60 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
39092 |
0.15 |
chr2_35589940_35590249 | 6.59 |
Dab2ip |
disabled 2 interacting protein |
7254 |
0.2 |
chr11_94997403_94997585 | 6.57 |
Ppp1r9b |
protein phosphatase 1, regulatory subunit 9B |
1430 |
0.27 |
chr6_51270380_51270840 | 6.57 |
Mir148a |
microRNA 148a |
700 |
0.72 |
chr15_80130528_80130702 | 6.56 |
Tab1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
2512 |
0.17 |
chr13_45130524_45130902 | 6.55 |
Gm40932 |
predicted gene, 40932 |
23820 |
0.16 |
chr3_30999453_30999632 | 6.52 |
Prkci |
protein kinase C, iota |
3795 |
0.19 |
chr1_181853096_181853346 | 6.51 |
Gm5533 |
predicted gene 5533 |
32 |
0.97 |
chr8_120279515_120279706 | 6.50 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
51154 |
0.11 |
chr11_115832413_115832610 | 6.50 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
543 |
0.61 |
chr4_141131176_141131537 | 6.50 |
Szrd1 |
SUZ RNA binding domain containing 1 |
8371 |
0.11 |
chr13_59738884_59739054 | 6.46 |
1700014D04Rik |
RIKEN cDNA 1700014D04 gene |
3781 |
0.09 |
chr11_33911055_33911361 | 6.46 |
Kcnmb1 |
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
51805 |
0.14 |
chr14_115040506_115042372 | 6.45 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr4_132428123_132428546 | 6.44 |
Phactr4 |
phosphatase and actin regulator 4 |
5845 |
0.1 |
chr6_55358862_55359046 | 6.42 |
Ghrhr |
growth hormone releasing hormone receptor |
17341 |
0.14 |
chr9_48724004_48724401 | 6.41 |
Zbtb16 |
zinc finger and BTB domain containing 16 |
111743 |
0.06 |
chr1_184645673_184645857 | 6.41 |
Gm37800 |
predicted gene, 37800 |
16292 |
0.15 |
chr5_36620484_36620644 | 6.39 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
691 |
0.54 |
chr19_6276450_6277434 | 6.38 |
Ehd1 |
EH-domain containing 1 |
17 |
0.81 |
chr2_170142692_170142843 | 6.38 |
Zfp217 |
zinc finger protein 217 |
89 |
0.98 |
chr6_91660192_91660417 | 6.38 |
Gm45217 |
predicted gene 45217 |
18919 |
0.12 |
chr8_108819933_108820141 | 6.38 |
Gm38318 |
predicted gene, 38318 |
47525 |
0.15 |
chr11_106580553_106580733 | 6.37 |
Tex2 |
testis expressed gene 2 |
43 |
0.98 |
chr12_99426276_99426469 | 6.36 |
Foxn3 |
forkhead box N3 |
13767 |
0.17 |
chr4_150798850_150799180 | 6.35 |
Gm13049 |
predicted gene 13049 |
26718 |
0.15 |
chr11_11521880_11522061 | 6.34 |
Spata48 |
spermatogenesis associated 48 |
32704 |
0.14 |
chr5_36737397_36737579 | 6.31 |
Gm43701 |
predicted gene 43701 |
11130 |
0.13 |
chr15_78986929_78987080 | 6.31 |
Triobp |
TRIO and F-actin binding protein |
3299 |
0.1 |
chr9_106724913_106725237 | 6.26 |
Rad54l2 |
RAD54 like 2 (S. cerevisiae) |
2204 |
0.26 |
chr8_106136293_106136737 | 6.25 |
Esrp2 |
epithelial splicing regulatory protein 2 |
170 |
0.8 |
chr13_37913191_37913355 | 6.25 |
Rreb1 |
ras responsive element binding protein 1 |
24402 |
0.18 |
chr9_102995959_102996111 | 6.24 |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
7323 |
0.17 |
chr9_58656902_58657105 | 6.23 |
Rec114 |
REC114 meiotic recombination protein |
2289 |
0.28 |
chr8_123982265_123983435 | 6.23 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
272 |
0.84 |
chr10_30749829_30750179 | 6.22 |
Gm48335 |
predicted gene, 48335 |
6042 |
0.16 |
chr10_99255973_99256147 | 6.18 |
Dusp6 |
dual specificity phosphatase 6 |
7171 |
0.11 |
chr8_126845072_126845223 | 6.17 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
5914 |
0.22 |
chr3_94686634_94686801 | 6.16 |
Selenbp2 |
selenium binding protein 2 |
6839 |
0.11 |
chr15_99029765_99030391 | 6.11 |
Tuba1c |
tubulin, alpha 1C |
187 |
0.88 |
chr18_84888729_84888882 | 6.11 |
Cyb5a |
cytochrome b5 type A (microsomal) |
11204 |
0.16 |
chr11_115824174_115824625 | 6.10 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
341 |
0.77 |
chr19_53251108_53251317 | 6.10 |
1700001K23Rik |
RIKEN cDNA 1700001K23 gene |
3978 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
3.1 | 9.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
3.0 | 8.9 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
2.9 | 11.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
2.7 | 16.4 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
2.6 | 10.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
2.3 | 6.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.3 | 6.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.1 | 10.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.1 | 6.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
2.0 | 6.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.9 | 5.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.8 | 7.4 | GO:0008228 | opsonization(GO:0008228) |
1.8 | 7.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.8 | 5.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.8 | 5.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.7 | 8.7 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
1.7 | 5.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.7 | 8.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.7 | 15.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
1.7 | 6.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.6 | 4.8 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.6 | 6.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.6 | 3.1 | GO:0015793 | glycerol transport(GO:0015793) |
1.6 | 10.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.5 | 4.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.4 | 4.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.4 | 4.2 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.4 | 5.6 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
1.4 | 5.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.4 | 4.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.4 | 6.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.4 | 5.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.3 | 5.3 | GO:0032264 | IMP salvage(GO:0032264) |
1.3 | 6.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.3 | 9.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
1.3 | 4.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.3 | 6.4 | GO:0015886 | heme transport(GO:0015886) |
1.3 | 10.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.3 | 5.0 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.2 | 3.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.2 | 4.8 | GO:1903726 | negative regulation of phospholipid biosynthetic process(GO:0071072) negative regulation of phospholipid metabolic process(GO:1903726) |
1.2 | 7.2 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
1.2 | 7.0 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.2 | 2.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.2 | 3.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.1 | 7.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.1 | 4.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.1 | 3.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.1 | 3.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.1 | 3.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.1 | 4.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.1 | 7.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.0 | 7.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.0 | 2.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.0 | 6.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.0 | 4.1 | GO:0007418 | ventral midline development(GO:0007418) |
1.0 | 1.0 | GO:0070627 | ferrous iron import(GO:0070627) |
1.0 | 5.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.0 | 4.9 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.0 | 2.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.0 | 4.8 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.0 | 7.7 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
1.0 | 3.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.9 | 2.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.9 | 3.8 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.9 | 2.8 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.9 | 1.9 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.9 | 4.6 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.9 | 2.7 | GO:0040031 | snRNA modification(GO:0040031) |
0.9 | 2.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.9 | 1.8 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.9 | 4.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.9 | 3.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.9 | 3.5 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.9 | 1.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.9 | 2.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.8 | 3.4 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.8 | 3.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.8 | 4.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.8 | 5.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.8 | 2.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.8 | 4.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.8 | 2.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.8 | 9.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.8 | 1.6 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.8 | 1.6 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.8 | 6.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.8 | 4.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.8 | 2.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.8 | 2.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.8 | 4.5 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.8 | 9.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.8 | 1.5 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.8 | 2.3 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.7 | 1.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.7 | 0.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.7 | 3.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 4.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.7 | 0.7 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.7 | 4.4 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.7 | 2.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.7 | 1.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 4.2 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.7 | 2.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.7 | 0.7 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.7 | 2.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.7 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.7 | 5.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.7 | 4.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.7 | 2.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.7 | 2.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 2.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.7 | 6.7 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.7 | 1.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.7 | 1.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.7 | 1.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.7 | 2.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 0.7 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.7 | 2.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.7 | 3.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.7 | 2.6 | GO:0009838 | abscission(GO:0009838) |
0.7 | 2.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.6 | 1.9 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.6 | 1.3 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.6 | 1.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.6 | 1.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 2.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.6 | 3.8 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.6 | 3.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.6 | 3.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 3.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 1.9 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.6 | 1.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 1.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.6 | 1.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.6 | 0.6 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.6 | 0.6 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.6 | 1.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.6 | 1.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.6 | 0.6 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.6 | 6.2 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.6 | 1.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.6 | 2.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.6 | 1.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.6 | 1.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 3.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.6 | 1.8 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.6 | 2.4 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.6 | 5.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.6 | 6.0 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.6 | 3.0 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.6 | 4.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.6 | 4.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.6 | 1.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 1.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.6 | 1.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.6 | 3.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 3.5 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.6 | 1.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.6 | 4.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.6 | 2.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.6 | 0.6 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.6 | 1.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.6 | 2.2 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.6 | 2.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.6 | 2.8 | GO:1904970 | brush border assembly(GO:1904970) |
0.6 | 1.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 2.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 1.7 | GO:0097501 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) stress response to copper ion(GO:1990169) |
0.6 | 2.2 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.5 | 2.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.5 | 1.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.5 | 1.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.5 | 2.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.5 | 1.6 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 2.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.5 | 0.5 | GO:0061724 | lipophagy(GO:0061724) |
0.5 | 4.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.5 | 1.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.5 | 1.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.5 | 6.3 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.5 | 3.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 1.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.5 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 3.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 3.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 1.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 3.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.5 | 0.5 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.5 | 1.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.5 | 3.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 3.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.5 | 6.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.5 | 1.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 2.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 2.5 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 0.5 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.5 | 2.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.5 | 2.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.5 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.5 | 0.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 1.0 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.5 | 2.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 1.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.5 | 1.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.5 | 4.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.5 | 2.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 2.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.5 | 1.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 1.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 1.4 | GO:0070254 | mucus secretion(GO:0070254) |
0.5 | 16.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.5 | 0.9 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 0.5 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.5 | 0.5 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.5 | 3.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.5 | 3.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.5 | 5.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 1.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 0.9 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.4 | 0.9 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.4 | 1.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 0.4 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.4 | 1.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 1.3 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 0.9 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.4 | 3.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 0.4 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.4 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 1.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 1.7 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.4 | 0.9 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.4 | 1.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 2.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 1.3 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 2.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 3.0 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.4 | 0.9 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.4 | 3.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.4 | 1.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.4 | 4.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.4 | 0.4 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.4 | 2.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 2.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.4 | 3.7 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.4 | 1.2 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 2.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 2.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 2.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 1.6 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.4 | 0.8 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 1.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 2.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.4 | 1.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 4.8 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.4 | 1.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 1.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 1.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.4 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.4 | 2.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 0.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 1.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 1.5 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.4 | 0.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.4 | 0.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 1.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 4.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 0.8 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.4 | 4.9 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.4 | 1.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 3.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 1.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 1.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.4 | 1.5 | GO:0007343 | egg activation(GO:0007343) |
0.4 | 1.5 | GO:0018214 | protein carboxylation(GO:0018214) |
0.4 | 2.9 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.4 | 1.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.4 | 0.4 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.4 | 0.7 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.4 | 4.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 0.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.4 | 4.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.4 | 1.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.4 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 1.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.4 | 1.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.4 | 1.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.4 | 2.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 2.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 1.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 2.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 2.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 3.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 0.7 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 1.7 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 1.4 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 4.8 | GO:0035196 | dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.3 | 0.7 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 0.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.3 | 0.7 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 0.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 2.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 7.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 2.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 1.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 3.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 3.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.3 | 1.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 5.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 3.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 1.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 1.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.3 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 2.0 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.3 | 2.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 0.7 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 1.3 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 0.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 0.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 3.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 4.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 1.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 0.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.3 | 1.3 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.3 | 1.0 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 1.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 5.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.3 | 3.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.3 | 1.6 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.3 | 1.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.3 | 1.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 1.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 3.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.3 | 2.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 1.5 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) |
0.3 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 1.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.6 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 2.1 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.9 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 7.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 0.9 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
0.3 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 3.0 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.3 | 1.8 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.3 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.3 | 0.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 3.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.3 | 0.3 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 0.3 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.3 | 0.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 0.3 | GO:0021586 | pons maturation(GO:0021586) |
0.3 | 9.8 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 1.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 2.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 2.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 1.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 1.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 0.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 0.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 0.3 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.3 | 0.3 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 1.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.3 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 2.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 1.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 2.5 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.3 | 1.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 0.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 0.3 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.3 | 1.9 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 0.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 0.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 0.5 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.1 | GO:0000237 | leptotene(GO:0000237) |
0.3 | 0.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 0.8 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.3 | 2.9 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.3 | 3.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 3.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 0.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 1.6 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.3 | 1.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 5.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 1.0 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.3 | 0.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.3 | 0.5 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 0.3 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 1.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 7.5 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.3 | 3.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 1.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 1.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 2.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 1.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.5 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.3 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.3 | 0.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 0.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.3 | 1.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.5 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 1.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.7 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.5 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.2 | 2.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 2.7 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 4.7 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.2 | 0.5 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.2 | 0.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 1.5 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.2 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 2.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.5 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.2 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.7 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 3.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 3.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 1.0 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.2 | GO:0060066 | oviduct development(GO:0060066) |
0.2 | 2.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 1.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.2 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.9 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 0.7 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 0.5 | GO:0051029 | rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.2 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 3.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.2 | 3.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 5.4 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.2 | 0.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.2 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.5 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 0.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.7 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 2.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 7.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 19.3 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.2 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 0.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.6 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 2.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 1.1 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.2 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.2 | 2.9 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 3.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 1.3 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.2 | 2.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.7 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 2.6 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 0.2 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.2 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 2.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 1.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 1.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 0.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 2.1 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.2 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 0.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.4 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.2 | 0.8 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 1.7 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.8 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 0.4 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 2.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.2 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.8 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.2 | 1.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 2.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.2 | 1.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 2.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 1.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.2 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.4 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.2 | 0.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.6 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.2 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 1.0 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
0.2 | 1.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.2 | 1.4 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.6 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 1.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.4 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 1.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 4.7 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.2 | 2.1 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.2 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 2.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 2.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 1.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.2 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.2 | 4.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 0.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.2 | 2.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 3.6 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 2.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.2 | 0.8 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 0.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 1.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.6 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 1.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 2.0 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.2 | 0.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 0.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 1.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.5 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 1.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.5 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.9 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 0.4 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.2 | 1.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.7 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.2 | 0.9 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.2 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 2.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 2.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.2 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.2 | 2.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.0 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.2 | GO:0072604 | interleukin-6 secretion(GO:0072604) |
0.2 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.2 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 1.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 1.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.7 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.2 | 1.9 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.3 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.2 | 0.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 1.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 1.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 9.9 | GO:0043627 | response to estrogen(GO:0043627) |
0.2 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.3 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.5 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.2 | 0.3 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.2 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 4.4 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 1.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 1.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 1.0 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.6 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.2 | 0.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.8 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.2 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 2.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 0.5 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 1.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 1.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.2 | 2.3 | GO:0019068 | virion assembly(GO:0019068) |
0.2 | 0.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.2 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.2 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 0.5 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 1.5 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.9 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 1.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.9 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.0 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 6.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.9 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.1 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 1.4 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.1 | 1.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 2.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 8.2 | GO:0001890 | placenta development(GO:0001890) |
0.1 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 4.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 1.5 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.6 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 1.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 1.0 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.1 | 0.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.6 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 0.6 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.3 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 5.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 1.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.3 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.1 | 0.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 1.0 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 1.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.5 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.7 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 1.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.1 | 0.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.1 | 0.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 2.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 17.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 5.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.5 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.5 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 1.0 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.5 | GO:0043470 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.1 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 1.4 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.6 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.4 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 1.1 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.1 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.5 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.2 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 2.2 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.5 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 1.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.0 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.4 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.4 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 1.2 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.2 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.7 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 3.7 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 6.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 1.8 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 3.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 1.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.6 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.1 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 2.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 1.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.8 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 2.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.3 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 4.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.1 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.1 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.5 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.1 | GO:0043092 | L-amino acid import(GO:0043092) |
0.1 | 0.9 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 0.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.3 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.1 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 1.6 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.1 | 0.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.8 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.7 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 0.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.1 | 0.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 1.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.2 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
0.1 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 1.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.7 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.1 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.3 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 1.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 1.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.3 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.1 | 2.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 1.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 3.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.3 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.7 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.6 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 2.0 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.4 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.3 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.1 | 0.3 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.2 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.2 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 1.4 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.9 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.2 | GO:0051875 | pigment granule localization(GO:0051875) |
0.1 | 0.7 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 2.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.1 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.7 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 1.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.1 | 0.5 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.3 | GO:0000050 | urea cycle(GO:0000050) arginine biosynthetic process(GO:0006526) urea metabolic process(GO:0019627) |
0.1 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.1 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.1 | 0.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.1 | GO:0042701 | progesterone secretion(GO:0042701) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 1.0 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.1 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.1 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 1.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.5 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.1 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 1.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 2.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
0.1 | 1.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.3 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.1 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.4 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 1.7 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.1 | 0.3 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 1.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.1 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.1 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.2 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.7 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.4 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.1 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.1 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.7 | GO:0006949 | syncytium formation(GO:0006949) |
0.1 | 0.1 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.8 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.2 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.1 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.1 | GO:0001878 | response to yeast(GO:0001878) neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.7 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.7 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.5 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.2 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.4 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 1.3 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.1 | 0.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.1 | 2.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.3 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.0 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.0 | 0.2 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.2 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.0 | 0.0 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.1 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.2 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.0 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.0 | GO:0033875 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.0 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.1 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 4.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.0 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.0 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.2 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.0 | 0.0 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.0 | 0.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.0 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.0 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:0097240 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.6 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.2 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.0 | 2.0 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.0 | 0.0 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.0 | 0.0 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.1 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.0 | 0.2 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.1 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 2.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.2 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.1 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.1 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0002034 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.4 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.0 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.4 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:1905153 | regulation of membrane invagination(GO:1905153) |
0.0 | 0.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 3.5 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.0 | GO:1902930 | regulation of alcohol biosynthetic process(GO:1902930) |
0.0 | 0.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.2 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.0 | 0.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.0 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.0 | 0.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.1 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.0 | GO:0072283 | metanephric renal vesicle morphogenesis(GO:0072283) |
0.0 | 0.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.3 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.0 | 0.0 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.0 | 0.0 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.0 | 0.0 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.0 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus development(GO:0060482) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.0 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.0 | 0.0 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.0 | 0.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.0 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.0 | 0.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.0 | 0.0 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.2 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.2 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.0 | 0.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.0 | GO:0051307 | male meiosis chromosome segregation(GO:0007060) meiotic chromosome separation(GO:0051307) |
0.0 | 0.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.1 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.0 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 0.5 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.0 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.0 | 0.1 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 0.0 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.0 | 0.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.0 | 0.0 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.0 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.0 | 0.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.0 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.0 | 0.0 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.0 | 0.0 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.0 | 0.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.0 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.0 | 0.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.0 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.1 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.0 | 0.0 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.0 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.4 | 7.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.3 | 11.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.9 | 5.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.8 | 7.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.7 | 5.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.7 | 11.6 | GO:0042382 | paraspeckles(GO:0042382) |
1.6 | 8.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.6 | 8.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.5 | 4.4 | GO:0097513 | myosin II filament(GO:0097513) |
1.3 | 4.0 | GO:1990357 | terminal web(GO:1990357) |
1.2 | 7.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.1 | 3.4 | GO:0097443 | sorting endosome(GO:0097443) |
1.1 | 3.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.1 | 4.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.1 | 3.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.0 | 5.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.0 | 6.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.0 | 3.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 2.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.9 | 2.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.9 | 2.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.9 | 3.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.9 | 1.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.8 | 3.3 | GO:0042825 | TAP complex(GO:0042825) |
0.8 | 6.5 | GO:0045179 | apical cortex(GO:0045179) |
0.8 | 3.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.8 | 4.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.8 | 1.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.8 | 2.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.7 | 13.1 | GO:0043034 | costamere(GO:0043034) |
0.7 | 2.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 2.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.6 | 0.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 2.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 5.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.6 | 1.9 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.6 | 1.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 2.5 | GO:0030689 | Noc complex(GO:0030689) |
0.6 | 2.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 2.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 2.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 7.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 2.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 5.3 | GO:0034709 | methylosome(GO:0034709) |
0.5 | 2.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 2.1 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.5 | 7.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 1.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 1.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.5 | 4.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.5 | 3.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 1.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.5 | 1.4 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 2.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 1.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 0.9 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 6.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 6.9 | GO:0097546 | ciliary base(GO:0097546) |
0.4 | 3.2 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 0.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 2.7 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 9.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 1.5 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 1.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 2.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 2.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 1.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 5.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 4.9 | GO:0031011 | Ino80 complex(GO:0031011) |
0.3 | 5.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 2.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 5.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 1.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 2.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 2.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 4.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 5.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 3.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 22.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 1.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 3.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 0.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 1.3 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 5.0 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.3 | 2.8 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 5.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.3 | 1.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 0.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 3.0 | GO:0031430 | M band(GO:0031430) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 8.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 1.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 16.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 5.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 0.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 11.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 1.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 2.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 0.8 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 1.7 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 4.8 | GO:0031672 | A band(GO:0031672) |
0.3 | 0.8 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 2.7 | GO:0005685 | U1 snRNP(GO:0005685) |
0.3 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 2.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 6.7 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 1.8 | GO:0000801 | central element(GO:0000801) |
0.3 | 14.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 2.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 10.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 2.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 3.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.5 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 2.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 1.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 7.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 1.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 2.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.9 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 1.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.7 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.2 | 1.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 2.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 2.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 13.4 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 11.5 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 3.5 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 1.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 1.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 2.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 5.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 8.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 2.9 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 4.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 3.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 0.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 15.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 4.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 6.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 1.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 4.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.7 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 3.5 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 4.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 2.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 7.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 0.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 6.3 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 2.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 4.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 0.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 38.9 | GO:0005925 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
0.2 | 1.7 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.2 | 1.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 23.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.2 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 1.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 6.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 16.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 2.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.9 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 2.8 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 2.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 6.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 2.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.9 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.6 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 1.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 3.1 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 4.9 | GO:1902493 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 2.1 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.5 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 4.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 3.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 2.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 3.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 3.5 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 23.4 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 2.9 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 6.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.7 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 2.5 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 1.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 7.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 1.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 102.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 24.6 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 1.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 8.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 7.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 2.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.2 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 14.5 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 36.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.1 | 2.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 2.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 26.8 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 2.9 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 2.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 3.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.0 | GO:0002141 | stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.0 | 0.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.0 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 29.3 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.5 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.0 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.0 | 0.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.0 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.6 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 11.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.4 | 9.7 | GO:0015265 | urea channel activity(GO:0015265) |
2.1 | 8.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.9 | 7.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.9 | 11.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.8 | 5.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.8 | 5.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.6 | 12.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.6 | 6.3 | GO:0015232 | heme transporter activity(GO:0015232) |
1.5 | 7.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.4 | 12.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.3 | 4.0 | GO:0097016 | L27 domain binding(GO:0097016) |
1.3 | 9.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.2 | 3.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.2 | 3.6 | GO:0042731 | PH domain binding(GO:0042731) |
1.2 | 7.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.1 | 1.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.1 | 4.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.1 | 4.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.1 | 3.2 | GO:0008142 | oxysterol binding(GO:0008142) |
1.1 | 3.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.0 | 2.1 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
1.0 | 3.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.0 | 4.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.9 | 2.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.9 | 8.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.9 | 8.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.9 | 2.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 3.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.8 | 2.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.8 | 7.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.8 | 1.6 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.8 | 3.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.8 | 0.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.8 | 3.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 5.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.8 | 2.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 2.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.8 | 2.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.8 | 6.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.8 | 2.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.7 | 3.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.7 | 5.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 2.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 2.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.7 | 1.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.7 | 2.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 2.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.7 | 2.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 2.2 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.7 | 2.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.7 | 2.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.7 | 12.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 5.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.7 | 3.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 2.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 4.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.7 | 2.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 4.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 5.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.6 | 2.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 2.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 8.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 4.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 6.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.6 | 1.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.6 | 4.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.6 | 1.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 9.0 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 0.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.6 | 1.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.6 | 2.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.6 | 2.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 1.7 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.6 | 1.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 11.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 10.8 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 2.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.6 | 3.9 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.6 | 1.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 1.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.6 | 8.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 11.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 3.8 | GO:0018640 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.5 | 0.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.5 | 3.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.5 | 2.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.5 | 3.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 1.5 | GO:0008495 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.5 | 1.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 2.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 5.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 2.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 1.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 8.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 3.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 7.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 3.3 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.5 | 1.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 4.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.5 | 0.9 | GO:0015250 | water channel activity(GO:0015250) |
0.5 | 2.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 7.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 1.4 | GO:0005119 | smoothened binding(GO:0005119) |
0.5 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 1.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 2.3 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 1.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 1.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 1.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.4 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.4 | 10.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 3.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 12.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 8.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 1.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 3.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 0.4 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.4 | 4.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 0.4 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.4 | 2.1 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 0.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 2.1 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 3.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 40.0 | GO:0002020 | protease binding(GO:0002020) |
0.4 | 0.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 2.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.6 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 1.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 1.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.4 | 1.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 1.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 5.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 4.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 6.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 1.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 2.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 1.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 1.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 2.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 1.8 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 4.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 5.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 1.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 0.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 2.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 4.6 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.4 | 1.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.4 | 0.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 1.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 3.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 5.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 4.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 2.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 1.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 1.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 4.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 0.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 1.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 3.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 1.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 5.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 9.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 2.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 4.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 0.3 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 2.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 3.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 2.4 | GO:0034821 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 1.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 2.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 1.5 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 2.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.4 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 2.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 3.9 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.3 | 2.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 2.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 4.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 2.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 7.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 2.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 5.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 2.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 7.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 0.8 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 3.0 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.3 | 2.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 16.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.3 | 2.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 1.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.7 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 3.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 3.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 5.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.2 | 0.7 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 2.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 3.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 6.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 2.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 0.2 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 2.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.9 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 1.9 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 0.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 1.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 2.3 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 2.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 1.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 6.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 1.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 3.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 4.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.2 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.2 | 2.3 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 1.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 3.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 1.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 3.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 3.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 0.6 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 1.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.4 | GO:0051379 | epinephrine binding(GO:0051379) |
0.2 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 2.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 3.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 0.4 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 1.2 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.4 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 1.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 0.7 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 3.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 2.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 2.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 2.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 1.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 4.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 2.7 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 3.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 0.4 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.2 | 2.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 3.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 1.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 1.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.2 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 2.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 16.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 2.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 2.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 1.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 7.5 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.3 | GO:0032564 | dATP binding(GO:0032564) |
0.2 | 1.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 3.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.9 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 6.9 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 0.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 4.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.6 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 4.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 2.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 3.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 1.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 3.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 1.1 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 1.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 2.0 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 1.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 4.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 2.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.9 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 3.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 8.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 2.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 3.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 1.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 2.9 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.9 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 2.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 3.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.9 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 2.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.9 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 19.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 12.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 2.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 19.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 1.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 3.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 1.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.4 | GO:0070325 | low-density lipoprotein particle receptor binding(GO:0050750) lipoprotein particle receptor binding(GO:0070325) |
0.1 | 0.9 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 6.5 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 11.3 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 6.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 5.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 1.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 1.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 1.8 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 1.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 6.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 4.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 17.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 5.4 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.2 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 1.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.3 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.1 | 2.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.7 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 1.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.9 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 11.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 1.2 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.1 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.1 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) antibiotic transporter activity(GO:0042895) |
0.1 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 6.5 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.8 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 1.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 2.0 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 5.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.3 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 10.8 | GO:0019900 | kinase binding(GO:0019900) |
0.1 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0047074 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.1 | 1.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.5 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 2.9 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 1.1 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.9 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.4 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.0 | 0.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 1.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.7 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 5.5 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 1.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.3 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 18.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.4 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.0 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0052850 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 1.8 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.6 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 1.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 1.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 1.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.0 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.0 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.0 | GO:0035671 | enone reductase activity(GO:0035671) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 11.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.8 | 6.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 9.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 14.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 9.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 3.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 6.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 11.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 20.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 16.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 9.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 5.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 13.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 3.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 12.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 1.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 4.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 4.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 4.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 10.4 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 3.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 7.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 9.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 5.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 5.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 2.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 7.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 3.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 13.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 5.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 3.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 8.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 4.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 25.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 6.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 3.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 2.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 3.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 2.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 1.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 5.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 7.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 5.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 7.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 4.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 1.0 | PID ATM PATHWAY | ATM pathway |
0.2 | 3.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 0.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 2.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 3.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 5.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 2.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 4.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 4.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 5.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 4.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 3.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 4.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 3.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 3.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 2.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 5.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 12.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.1 | 1.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.0 | 10.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.0 | 3.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.9 | 8.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 11.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.8 | 8.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.8 | 1.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.7 | 7.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.7 | 9.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.7 | 10.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.7 | 3.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 7.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.6 | 7.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.6 | 9.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.6 | 11.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 6.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.5 | 6.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.5 | 5.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 14.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 15.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 6.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 4.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 14.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.5 | 6.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 12.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 5.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.5 | 1.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.5 | 2.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.4 | 3.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 4.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 3.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 4.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 2.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 2.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 10.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 8.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 17.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 3.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 6.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 4.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 4.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 3.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 1.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 3.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 7.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 3.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 7.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 2.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 3.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 5.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 21.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 3.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 4.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 3.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 8.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 5.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 7.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 4.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 8.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 2.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 2.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 7.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 5.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 1.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.3 | 3.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 4.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 3.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 3.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.2 | 4.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 5.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 1.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 4.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 0.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 3.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 4.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.1 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.2 | 2.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 3.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 3.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.0 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 3.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 1.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 2.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 6.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 5.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 1.3 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.5 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 4.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 1.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 0.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 2.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 2.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 1.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 0.7 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.2 | 3.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 5.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 2.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 6.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 1.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 1.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 3.8 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 4.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 5.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.7 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 1.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.5 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 5.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 0.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 9.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 1.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 3.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 3.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 2.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 15.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 2.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.1 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 13.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.4 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.3 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 4.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.7 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.1 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 5.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 2.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 4.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 1.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |